SEC 13F Intelligence

Harding Loevner LP / VRTX

Harding Loevner LP’s Vertex Pharmaceuticals Inc Position

Does Harding Loevner LP own Vertex Pharmaceuticals Inc (VRTX)? Yes — 313.5K shares worth $140M (+1.44% of its 13F portfolio) as of Q1 2026, down from 391.9K shares the prior filed quarter.

Position Value
$140M
Q1 2026
Shares
313.5K
% of Portfolio
+1.44%
Quarters Held
30
currently held

Position History VRTX

Reported value by quarter
Q4 ’18: $11,000Q4 ’18Q1 ’19: $138MQ2 ’19: $136MQ3 ’19: $394MQ4 ’19: $458MQ4 ’19Q1 ’20: $487MQ2 ’20: $587MQ3 ’20: $544MQ4 ’20: $483MQ4 ’20Q1 ’21: $426MQ2 ’21: $403MQ3 ’21: $347MQ4 ’21: $413MQ4 ’21Q1 ’22: $417MQ2 ’22: $489MQ3 ’22: $475MQ4 ’22: $532MQ4 ’22Q1 ’23: $576MQ2 ’23: $541MQ3 ’23: $468MQ4 ’23: $539MQ4 ’23Q1 ’24: $511MQ2 ’24: $555MQ3 ’24: $536MQ4 ’24: $332MQ4 ’24Q1 ’25: $339MQ2 ’25: $317MQ3 ’25: $179MQ4 ’25: $178MQ4 ’25Q1 ’26: $140Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026313.5K$140M+1.44%
Q4 2025391.9K$178M+1.56%
Q3 2025456.0K$179M+1.31%
Q2 2025711.6K$317M+2.13%
Q1 2025698.5K$339M+2.59%
Q4 2024823.6K$332M+2.24%
Q3 20241.15M$536M+3.09%
Q2 20241.18M$555M+3.06%
Q1 20241.22M$511M+3.16%
Q4 20231.32M$539M+3.02%
Q3 20231.35M$468M+3.09%
Q2 20231.54M$541M+3.16%
Q1 20231.83M$576M+3.28%
Q4 20221.84M$532M+3.06%
Q3 20221.64M$475M+3.11%
Q2 20221.73M$489M+3.01%
Q1 20221.77M$417M+2.30%
Q4 20211.88M$413M+1.58%
Q3 20211.91M$347M+1.38%
Q2 20212.00M$403M+1.52%
Q1 20211.98M$426M+1.67%
Q4 20202.04M$483M+2.00%
Q3 20202.00M$544M+1.96%
Q2 20202.02M$587M+2.81%
Q1 20202.05M$487M+2.72%
Q4 20192.09M$458M+2.04%
Q3 20192.32M$394M+1.86%
Q2 2019740.4K$136M+0.62%
Q1 2019752.0K$138M+0.65%
Q4 201869$11,0000.00%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Harding Loevner LP’s full portfolio or all institutional holders of VRTX.